Jeffrey Black

Jeffrey G.
Black is currently Director at Cellana, Inc. and Cellana LLC, Director at SomaLogic, Inc. since 2024, Chief Financial Officer at Lpath Therapeutics, Inc., Chief Financial Officer at Apollo Endosurgery International LLC, Controller at Chiron Mimotopes Peptide Systems LLC, and Secretary, Chief Financial & Accounting Officer at Exagen, Inc. since 2024.
Former positions include Executive Director-Accounting & Controller at Ionis Pharmaceuticals, Inc. from 2003 to 2005, Controller at Triteal Corp., Vice President & Controller at Clarent Corp., Controller at Lightspan, Inc., Executive VP, Chief Financial & Accounting Officer at Alphatec Holdings, Inc. from 2017 to 2021, Chief Financial Officer at AltheaDx, Inc. from 2014 to 2015, Vice President & Controller at Accelerated Networks, Inc., Chief Financial Officer & Executive Vice President at Alphatec Spine, Inc., Chief Accounting Officer & Senior Vice President at Verenium Corp.
in 2011, Principal at Regent Pacific Management Corp.
from 2000 to 2003, Chief Financial Officer at Applied Proteomics, Inc. from 2015 to 2017, Chief Financial Officer, Secretary & Treasurer at Apollo Endosurgery, Inc. from 2021 to 2023, and Chief Financial & Accounting Officer, SVP at Standard BioTools, Inc. from 2023 to 2024.
Education includes an undergraduate degree from the University of Arizona conferred in 1991.